Sage Therapeutics Inc

NASDAQ:SAGE   3:59:55 PM EDT
38.56
-0.66 (-1.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.25B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.68 Million
Adjusted EPS-$2.22
See more estimates
10-Day MA$39.89
50-Day MA$39.38
200-Day MA$36.92
See more pivots

Sage Therapeutics Inc Stock, NASDAQ:SAGE

215 1st Street, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.299.8380
Number of Employees: 471

Description

SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel medicines. It targets diseases and disorders of the brain with three key focus areas: depression, neurology, and neuropsychiatry. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010, and is headquartered in Cambridge, MA.